AegirBio is a precision diagnostics company that aims to optimize the dosage of biological drugs through its unique patented technology platform. With core technologies from LifeAssays and Abreos Biosciences, AegirBio combines the expertise of two leading companies in the field. They offer a range of products and services to address the growing demand for accurate drug dosing in the pharmaceutical industry.

Using their laboratory-developed tests, AegirBio allows for the follow-up of patients during treatment with biological drugs. Their point-of-care solutions provide quantitative near-patient tests for routine control in clinics and health centers. Additionally, they offer point-of-need and rapid tests, including quantitative home tests for chronic diseases and indicative rapid tests.

By leveraging their acquisitions and technologies, AegirBio is expanding its capabilities to become a multi-diagnostic company. They are dedicated to developing new diagnostics that are accessible, easy to use, and provide accurate results. With the goal of making diagnostics more convenient and transferable, AegirBio is revolutionizing the field of precision diagnostics